FDA Considers Stronger Warnings for Yasmin and Yaz

By Moe Taheri

December 9, 2011 – Yaz and Yasmin may cause a significantly higher risk of blood clots compared to older birth control pills. These recent medical findings were reviewed yesterday by an FDA advisory committee that is evaluating the risks and benefits of Yaz and Yasmin. An FDA safety report prepared for the committee recommends a stronger warning about the “very real” possibility of an increased risk of blood clots.

Dr. Kessler, a former ranking member of the FDA, previously gave testimony that Bayer intentionally withheld important safety data to mislead FDA officials. This testimony was not considered at the committee hearings because it was submitted after the deadline. The FDA also barred the testimony of Dr. Sidney Wolfe as an FDA advisor due to a conflict of interest. Dr. Wolfe is a leading drug safety advocate with Public Citizen where Yaz is listed as a “do not use” medication.

Bayer’s failure to adequately warn about the risk of blood clots associated with Yaz and Yasmin has resulted in hundreds of lawsuits. The Nations Law Firm represents women who have suffered serious and potentially life-threatening injuries from Yaz and Yasmin.